Renaissance Technologies - TANDEM DIABETES CARE INC ownership

TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 269 filers reported holding TANDEM DIABETES CARE INC in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TANDEM DIABETES CARE INC
ValueSharesWeighting
Q3 2022$3,225,000
-64.4%
67,400
-56.0%
0.01%
-54.5%
Q2 2022$9,070,000
+256.1%
153,227
+599.7%
0.01%
+266.7%
Q1 2022$2,547,000
-30.2%
21,900
-9.6%
0.00%
-40.0%
Q4 2021$3,647,000
-87.2%
24,227
-89.9%
0.01%
-86.5%
Q3 2021$28,597,000
+752.9%
239,546
+595.8%
0.04%
+825.0%
Q2 2021$3,353,000
-77.8%
34,427
-79.9%
0.00%
-78.9%
Q1 2021$15,102,000
-50.1%
171,127
-45.9%
0.02%
-42.4%
Q4 2020$30,276,000
-39.8%
316,427
-28.6%
0.03%
-34.0%
Q3 2020$50,291,000
-39.1%
443,096
-47.0%
0.05%
-29.6%
Q2 2020$82,641,000
+159.5%
835,428
+68.8%
0.07%
+129.0%
Q1 2020$31,849,000
-22.0%
494,928
-27.7%
0.03%0.0%
Q4 2019$40,827,000
-46.5%
684,900
-47.1%
0.03%
-52.3%
Q3 2019$76,298,000
+31.7%
1,293,627
+44.1%
0.06%
+27.5%
Q2 2019$57,934,000
+17.8%
897,927
+15.9%
0.05%
+13.3%
Q1 2019$49,176,000
-8.3%
774,427
-45.2%
0.04%
-23.7%
Q4 2018$53,626,000
+216.4%
1,412,327
+257.0%
0.06%
+247.1%
Q3 2018$16,947,000
+218.3%
395,594
+8.8%
0.02%
+466.7%
Q2 2018$5,324,000
+582.6%
363,591
+131.3%
0.00%
+200.0%
Q1 2018$780,000
+1138.1%
157,227
+485.6%
0.00%
Q4 2017$63,00026,8500.00%
Other shareholders
TANDEM DIABETES CARE INC shareholders Q1 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,022,257$60,293,0005.97%
APIS CAPITAL ADVISORS, LLC 50,000$2,949,0004.62%
SECTORAL ASSET MANAGEMENT INC 432,815$25,527,0004.40%
CROWN ADVISORS MANAGEMENT, INC. 75,000$4,424,0002.96%
OBERWEIS ASSET MANAGEMENT INC/ 199,410$11,761,0002.66%
Asymmetry Capital Management, L.P. 18,995$1,120,0002.40%
Redmile Group, LLC 1,160,401$68,440,0002.29%
FRIESS ASSOCIATES LLC 501,985$29,607,0002.29%
Atika Capital Management LLC 142,000$8,375,0001.76%
Chicago Capital, LLC 433,083$25,543,0001.71%
View complete list of TANDEM DIABETES CARE INC shareholders